Delivery Order SPE2DB24D1007-SPE2DB24FCAKC
Award Date
9/10/24
Potential Completion Date
9/11/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,094.06 firm fixed price contract is for the supply of JATENZO 198 MG CAPSULE 120S, a pharmaceutical product. The award date is September 13, 2024, with an ultimate completion date of September 16, 2024. This delivery order is placed under one of Amerisourcebergen's Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical, valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.88 contract is for the supply of JATENZO 198 MG CAPSULE 120S, a medication, to be delivered by June 10, 2025. This order is part of AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product JATENZO 237 MG Capsule 120S. The contract has a firm fixed price of $2,188.14 and a completion date of September 20, 2024. AmerisourceBergen, as a major pharmaceutical distributor, will provide this medication to support military treatment facilities and other government healthcare programs. The contract does not have a set-aside designation....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,217.27, is for the supply of JATENZO 158 MG CAPSULE 120S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 13, 2025. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
This is a $2,312.78 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JATENZO 237 MG CAPSULE 120S, a prescription medication. The contract has an ultimate completion date of May 16, 2025. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is part...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product, with a firm fixed price of $3,365.22 and a period of performance through May 16, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JATENZO 158 MG CAPSULE 120S, a specialty pharmaceutical product, with a ceiling value of $1,094.06. The contract has a firm fixed price pricing type and a period of performance through October 28, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The order, valued at $1,304.79, is for the supply of JATENZO 237 MG CAPSULE 120S, a prescription medication. The contract is a firm fixed-price delivery order with an ultimate completion date of January 24, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,185.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product, with a completion date of March 19, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,152.31, is for the supply of JATENZO 237 MG CAPSULE 120S, a medical product, to support federal government healthcare programs. The contract has an ultimate completion date of January 21, 2025 and does not have a set-aside designation, indicating open competition....